Asia-Pacific Americas Africa Europe Middle East

PT PFIZER LNDONESIA

Company Profile:



Business Nature: Manufacturer (Factory)

Company Profile:

PT Pfizer Indonesia is a subsidiary of the global biopharmaceutical company Pfizer Inc. It operates as a manufacturing entity in Indonesia, dedicated to the production of pharmaceutical products to serve both the domestic market and international demand. The company manages a sophisticated manufacturing facility that adheres to strict global quality standards and Good Manufacturing Practices (GMP). Its core operations involve the formulation, production, and distribution of a wide range of innovative medicines and vaccines, focusing on addressing significant health challenges and improving patient outcomes through advanced medical research and local production capabilities.

Enterprise Products

PT Pfizer Indonesia manufactures or sells various pharmaceutical products across several therapeutic areas. These include:

Vaccines

Prevenar 13 (Pneumococcal Conjugate Vaccine)

Comirnaty (COVID-19 mRNA Vaccine)

Oncology (Cancer Treatments)

Ibrance (Palbociclib)

Sutent (Sunitinib)

Inflammation and Immunology

Xeljanz (Tofacitinib)

Internal Medicine and Cardiovascular

Lipitor (Atorvastatin)

Eliquis (Apixaban)

Lyrica (Pregabalin)

Anti-infectives and Antifungals

Diflucan (Fluconazole)

Central Nervous System

Zoloft (Sertraline)

Men's Health

Viagra (Sildenafil)

Business Registration Information:

Manager:

No Data

Phone:

+62 21 5084 1000

E-mail:

medical.information@pfizer.com

Official Website:
Address:

World Trade Center 3, 23rd Floor Jl. Jend. Sudirman Kav. 29-31 Karet Tengsin, Tanah Abang Central Jakarta 10210 Indonesia

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.